{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:44:02Z","timestamp":1782524642358,"version":"3.54.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Immune and cellular property shifts in human liver disease","award":["22JC1403002"],"award-info":[{"award-number":["22JC1403002"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Lack of efficient biomarkers and clinical translation of molecular typing impedes the implementation of targeted therapy for hepatocellular carcinoma (HCC). High-throughput sequencing techniques represented by next-generation sequencing (NGS) are tools for detecting targetable genes. The objective of this study is to explore the genetic alterations associated with clinicopathological features and the risk of recurrence\/metastasis in HCC. NGS analysis was conducted on formalin-fixed paraffin-embedded tissues from 164 resected liver samples obtained from Chinese patients. Morphologic subtypes were reviewed based on hematoxylin-eosin and immunohistochemistry staining, Correlation to the acquired molecular features were analyzed with clinicopathological information. We also retrieved follow-up information of the 123 transplanted cases from 2017 to 2019 to screen recurrence\/metastasis-associated factors by univariate analysis. Generally, the most frequently mutated genes include <jats:italic toggle=\"yes\">TP53<\/jats:italic> and <jats:italic toggle=\"yes\">CTNNB1<\/jats:italic> which showed a trend of mutually exclusive mutation. Copy-number variant with the highest frequency was detected in <jats:italic toggle=\"yes\">TAF1<\/jats:italic> and <jats:italic toggle=\"yes\">CCND1<\/jats:italic> in 11q13.3 loci. Correlation analysis showed that various genetic alterations were associated with morphologic subtypes and other pathologic features. While gene signatures of proliferation\/nonproliferation class were correlated with differentiation, satellite foci and other invasive morphological features. Macrotrabecular-massive subtype, <jats:italic toggle=\"yes\">TSC2<\/jats:italic> (tuberous sclerosis complex 2) mutation, Ki-67 expression, and other six factors were found to be associated with recurrence\/metastasis after liver transplantation. Genetic alterations detected by NGS show correlation with not only pathological and clinical features, but also with recurrence\/metastasis after liver transplantation. Further gene-level molecular typing will be practical for targeted therapy and individual recurrence risk assessment in HCC patients.<\/jats:p>","DOI":"10.1097\/cej.0000000000000939","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T13:01:05Z","timestamp":1733490065000},"page":"456-466","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Genetic alterations are related to clinicopathological features and risk of recurrence\/metastasis of hepatocellular carcinoma"],"prefix":"10.1097","volume":"34","author":[{"given":"Lili","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyue","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"},{"name":"Department of Pathology, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanghua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2017.12.018","article-title":"AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of \u03b2-catenin activation.","volume":"68","author":"Abitbol","year":"2018","journal-title":"J Hepatol"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jcp.28999","article-title":"Identification of TAF1, SAT1, and ARHGEF9 as DNA methylation biomarkers for hepatocellular carcinoma.","volume":"235","author":"Cai","year":"2020","journal-title":"J Cell Physiol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer.","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma.","volume":"169","year":"2017","journal-title":"Cell"},{"key":"R6-20250731","first-page":"309","article-title":"Molecular perspectives for the treatment of hepatocellular carcinoma.","volume":"83","author":"Demory","year":"2020","journal-title":"Acta Gastroenterol Belg"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/JHC.S217948","article-title":"Impact of next-generation sequencing on outcomes in hepatocellular carcinoma: how precise are we really?","volume":"7","author":"Dominguez","year":"2020","journal-title":"J Hepatocell Carcinoma"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood.2019004226","article-title":"NPM1-mutated acute myeloid leukemia: from bench to bedside.","volume":"136","author":"Falini","year":"2020","journal-title":"Blood"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"596789","DOI":"10.3389\/fonc.2021.596789","article-title":"Differential mutation detection capability through capture-based targeted sequencing in plasma samples in hepatocellular carcinoma.","volume":"11","author":"Gao","year":"2021","journal-title":"Front Oncol"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015.","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3350\/cmh.2021.0038","article-title":"Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma.","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"800679","DOI":"10.3389\/fmolb.2021.800679","article-title":"Somatic mutation profiles revealed by next generation sequencing (NGS) in 39 Chinese hepatocellular carcinoma patients.","volume":"8","author":"Ke","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/jclinpath-2016-203684","article-title":"Whole-genome profiling helps to classify phyllodes tumours of the breast.","volume":"69","author":"La\u00e9","year":"2016","journal-title":"J Clin Pathol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1038\/oncsis.2016.77","article-title":"Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S\/S gene with the sW172* mutation.","volume":"5","author":"Lai","year":"2016","journal-title":"Oncogenesis"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1097\/TP.0000000000003394","article-title":"Efficacy and safety of everolimus with reduced tacrolimus in liver transplant recipients: 24-month results from the pooled analysis of 2 randomized controlled trials.","volume":"105","author":"Lee","year":"2021","journal-title":"Transplantation"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3892\/or.2017.5946","article-title":"Screening and identification of key biomarkers in hepatocellular carcinoma: evidence from bioinformatic analysis.","volume":"38","author":"Li","year":"2017","journal-title":"Oncol Rep"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.7150\/jca.53124","article-title":"LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma.","volume":"12","author":"Liu","year":"2021","journal-title":"J Cancer"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.2147\/IJGM.S335592","article-title":"CSMD3 is associated with tumor mutation burden and immune infiltration in ovarian cancer patients.","volume":"14","author":"Lu","year":"2021","journal-title":"Int J Gen Med"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jpm8030030","article-title":"The role of next-generation sequencing in precision medicine: a review of outcomes in oncology.","volume":"8","author":"Morash","year":"2018","journal-title":"J Pers Med"},{"key":"R20-20250731","first-page":"528","article-title":"Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next-generation sequencing.","volume":"15","author":"Morishita","year":"2018","journal-title":"Oncol Lett"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.3748\/wjg.v22.i41.9069","article-title":"Genetic alterations in hepatocellular carcinoma: an update.","volume":"22","author":"Niu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"1073274817744621","DOI":"10.1177\/1073274817744621","article-title":"Liver resection and surgical strategies for management of primary liver cancer.","volume":"25","author":"Orcutt","year":"2018","journal-title":"Cancer Control"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"1019772","DOI":"10.3389\/fimmu.2022.1019772","article-title":"Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy.","volume":"13","author":"Qiao","year":"2022","journal-title":"Front Immunol"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma.","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J Hepatol"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"e937988","DOI":"10.12659\/AOT.937988","article-title":"Long-term effects of everolimus-facilitated tacrolimus reduction in living-donor liver transplant recipients with hepatocellular carcinoma.","volume":"27","author":"Sapisochin","year":"2022","journal-title":"Ann Transplant"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis.","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"172","DOI":"10.21037\/hbsn.2019.09.17","article-title":"Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients.","volume":"10","author":"Wang","year":"2021","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/gcc.22539","article-title":"Mutation analysis of adenomas and carcinomas of the colon: early and late drivers.","volume":"57","author":"Wolff","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"BSR20211053","DOI":"10.1042\/BSR20211053","article-title":"Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.","volume":"41","author":"Xu","year":"2021","journal-title":"Biosci Rep"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:00:39Z","timestamp":1753966839000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000939","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}